Number of the records: 1
Risk of residual cancer after complete response following first-line chemotherapy in men with metastatic non-seminomatous germ cell tumour and International Germ Cell Cancer Cooperative Group intermediate/poor prognosis: A multi-institutional retrospective cohort study
SYS 0189510 LBL 00000naa--2200000-a-4500 005 20250607180224.7 008 230623s2023----xo-----e------------eng-- 040 $a BA006 $b slo 041 0-
$a eng 044 $a xo $c SK 245 10
$a Risk of residual cancer after complete response following first-line chemotherapy in men with metastatic non-seminomatous germ cell tumour and International Germ Cell Cancer Cooperative Group intermediate/poor prognosis: A multi-institutional retrospective cohort study / $c Antonelli L., Mego M. ... [et al.] 500 $a Eur J Cancer. 2023 Mar;182:144-154 650 12
$7 sllk_us_auth*d009373 $a nádory z germinatívnych a embryonálnych buniek $2 mesh 650 12
$7 sllk_us_auth*d013724 $a teratóm $2 mesh 650 12
$7 sllk_us_auth*d018365 $a nádor reziduálny $2 mesh 650 22
$7 sllk_us_auth*d015996 $a miera prežívania $2 mesh 653 2-
$a nádory zo zárodočných buniek neseminomatózne metastatické 653 2-
$a vyhodnotenie súboru pacientov retrospektívne 655 -7
$7 sllk_us_auth*d004740 $a abstrakt v angličtine $2 mesh 700 1-
$7 sllk_us_auth*p0043304 $a Mego, Michal $u Klinika klinickej onkológie NOÚ, Bratislava $4 ant 710 2-
$7 sllk_us_auth*0012742 $a Redakcia Onkológia $4 adp 773 0-
$7 nnas $w sllk_us_cat*0188969 $t Onkológia $x 1336-8176 $d Bratislava : SOLEN, 2023 $g Roč. 18, č. 2 (2023), s. 160-161
Number of the records: 1